Navigation Links
Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial
Date:11/2/2010

and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause material differences include, among others, risks relating to: the successful preclinical development of our product candidates; the completion of our clinical trials; the review process of the FDA, the EMEA, other foreign regulatory bodies and other governmental regulatory bodies, including the FDA's and the EMEA's review of any filings we make in connection with the treatment protocol for taliglucerase alfa and including the risk that regulatory authorities may find that the data from our clinical trials and other studies is insufficient for regulatory approval; delays in the FDA's, the EMEA's or other health regulatory authorities' approval of any applications we file or refusals to approve such filings, including the NDA we filed with the FDA for taliglucerase alfa for the treatment of Gaucher disease; refusals by such regulatory authorities to approve the marketing and sale of a drug product even after acceptance of an application we file for any such drug product; and other factors described in our filings with the Securities and Exchange Commission. Companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in advanced or late-stage clinical trials, even after obtaining promising earlier trial results or in preliminary findings for such clinical trials. Further, even if favorable testing data is generated by clinical trials of drug products, the FDA, EMEA or any other foreign regulatory authority may not accept or approve an NDA filed by a pharmaceutical or biotechnology company for such drug product. Failure to obtain approval from the FDA, EMEA or any other foreign regulatory authority of any of our drug candidates in a timely
'/>"/>
SOURCE Protalix BioTherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences
2. Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
3. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
4. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
5. Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C
6. Talecris Biotherapeutics to Report Third Quarter 2010 Financial Results
7. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
8. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
9. NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
10. Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
11. Oxygen Biotherapeutics, Inc. Expands Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  Now available for sale, The Armor1 ... that prevents ankle sprains by cushioning the ankle from ... securely around the outside of any shoe type and ... while still offering protection against sprains. With customers in ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
(Date:1/23/2015)... Jan. 23, 2015   Leatt Corporation  (OTCQB: LEAT), a ... for all forms of sports, including extreme motor sports, ... announced today that the UISP Lega Motociclismo Lombardia, an ... riders to wear a neck brace during its racing ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3
... , June 17 www.hra-pharma.com -HRA Pharma ... Committee for Reproductive Health Drugs voted 11 to 0 that the ... effective and safe for use as an emergency contraceptive. , ... The committee,s vote followed ...
... Mylan Inc. (Nasdaq: MYL ) today announced that its ... Food and Drug Administration (FDA) for its Abbreviated New Drug ... and 50 mg. The product was determined to be bioequivalent ... treatment for nervousness and tension.   , ...
Cached Medicine Technology:FDA Advisory Committee Unanimously Recommends Approval of HRA Pharma's Ulipristal Acetate for Emergency Contraception 2FDA Advisory Committee Unanimously Recommends Approval of HRA Pharma's Ulipristal Acetate for Emergency Contraception 3Mylan Receives Approval for Hydroxyzine Hydrochloride Tablets 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Thousand of ... Medical Care recalled its GranuFlo and NaturaLyte dialysis concentrates ... underway in U.S. District Court, District of Massachusetts, Bernstein ... 20th, the Court has remanded a case filed by ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Joan Lunden, ... keynote speaker at the upcoming 32nd Annual Miami ... Physicians’ Education Resource®, LLC (PER®) , shares that ... have gone undetected if she had not followed up ...
(Date:1/22/2015)... Palm City, Florida (PRWEB) January 22, 2015 ... use cold therapy machine with patented IsoTube design to treat ... has introduced the most progressive and easy to use ... help treat post-operative and sports related orthopedic and muscle injuries. ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 As ... of overall health care gains momentum worldwide, Rev. Eric ... HealthCare Chaplaincy Network (HCCN), will be the keynote ... spiritual care in Israel’s public health system. , The conference, ...
(Date:1/22/2015)... Step into a macabre world where ... of Virginia. Wicked Plants, the Museum’s latest featured exhibition, ... poisonous, carnivorous and diabolical plants inside of a dilapidated, ... the biochemical, physical and neurological processes between botanicals and ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... MONDAY, Oct. 17 (HealthDay News) -- ,Fast speeds, lack of ... are among the reasons why thousands of American children are ... research. The findings were to be presented Monday at ... in Boston. According to the AAP, children account for ...
... By Randy Dotinga HealthDay Reporter , MONDAY, ... into fountains of four-letter words? Maybe so, says a new ... profanity-ridden shows and video games. However, the research ... swearing among kids, nor does it explain why non-aggressive cussing ...
... a home with a swimming pool are at risk of ... study abstract presented Monday, Oct. 17, at the American Academy ... three likely scenarios that precede the drowning of a very ... pool. In the study, "Patterns of Drowning in Young ...
... of Pennsylvania School of Nursing have found a link between ... are five times more likely to have autism than children ... small as about a pound, were followed for 21 years ... , one of the most remarkable of its kind. The ...
... cranial computed tomography (CT) scans in an emergency department ... children, a study by researchers at UC Davis has ... CT scans are underused in treating African-American and Hispanic ... children may receive too many CT scans -- and ...
... , SUNDAY, Oct. 16 (HealthDay News) -- Children ... with an "undesirable trait" if they believe it,s the ... study included 137 third- through eighth-grade students who were ... who were either a poor student or poor athlete, ...
Cached Medicine News:Health News:Too Many Kids Injured in ATV Crashes, Study Finds 2Health News:Profanity on TV Linked to Foul-Mouthed Kids 2Health News:Study identifies scenarios that precede at-home pool drownings of young children 2Health News:Low birthweight infants have five times rate of autism 2Health News:White children far more likely to receive CT scans than Hispanic, African-American children 2Health News:Kids Can Be Tougher on Obese Peers 2
...
... The TOPCON PD Meter, Model II, is ... accurate measurements are speedily obtained because it ... halves of the pupils, with internal reading ... well as nasal-pupillary distances. Since displacements between ...
... the future with the all-new EXAM-3000! ... efficiency, dramatically increase your patient flow ... and money. Todays demand for delegation ... the logical choice for the progressive ...
... of IMAGEnet Lite, a standard in powerful ... the Topcon TRC-NW6 or TRC-NW6S to assemble ... package. The system incorporates the latest advances ... retinal camera allowing a technician to perform ...
Medicine Products: